Abstract
99mTc-fanolesomab is a radiolabeled imaging agent which is being developed by Palatin Technologies for use in the diagnosis of various infections, including appendicitis and osteomyelitis.
MeSH terms
-
Animals
-
Antibodies, Monoclonal* / adverse effects
-
Antibodies, Monoclonal* / pharmacokinetics
-
Clinical Trials as Topic
-
Humans
-
Infections / diagnosis
-
Injections, Intravenous
-
Lewis X Antigen / metabolism
-
Radiopharmaceuticals* / adverse effects
-
Radiopharmaceuticals* / pharmacokinetics
-
Structure-Activity Relationship
-
Technetium*
Substances
-
Antibodies, Monoclonal
-
Lewis X Antigen
-
Radiopharmaceuticals
-
Technetium
-
techneticum TC-99M fanolesomab